Delivery Order SPE2DB20D2104-SPE2DB22FQ90N

Award Date 11/3/21
Potential Completion Date 11/4/21
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,574.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4565007273 - BELSOMRA 10 MG TABLET 30S, a pharmaceutical product. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $1,700.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BELSOMRA 20 MG TABLET 30S, a prescription medication. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 25, 2022. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This federal contract award, valued at $1,343.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BELSOMRA 5 MG TABLET 30S, a pharmaceutical product, with a completion date of December 2, 2022. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $2,567.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BELSOMRA 20 MG TABLET 30S, a pharmaceutical product. The award is part of an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,103.94 firm fixed-price delivery order is for the supply of BELSOMRA 10 MG TABLET 30S, a prescription medication. This award does not have a set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,132.22, is for the delivery of BELSOMRA 10 MG TABLET 30S, a prescription medication. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.08 Firm Fixed Price Delivery Order contract is for the supply of BELSOMRA 10 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.85 firm fixed-price delivery order is for the supply of Belsomra 10 mg tablets, a medication used to treat insomnia. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN64D, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,740.54 firm fixed-price delivery order contract is for the supply of BELSOMRA 20 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award is for the delivery of BELSOMRA 10 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,455.03 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 25, 2025, with a completion date of February 26, 2025. This delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FQ90N
    Delivery Order

This federal contract award, valued at $1,948.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BELSOMRA 10 MG TABLET 30S, a prescription medication.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a key supplier to federal agencies, Amerisourcebergen Drug Corp and its parent company Cencora, Inc. play a critical role in delivering essential medications and medical commodities to the U.S. Department of Defense and other government healthcare programs.

Generated 2/27/25, 10:51 AM